366 search results for “anti-cancer drug steen” in the Staff website
-
Charlie SteenFaculteit Governance and Global Affairs
c.a.steen@fgga.leidenuniv.nl | 070 8009500
-
Joesjka van der SteenUniversity Facility Services
j.van.der.steen@ufb.leidenuniv.nl | 071 5272727
-
Tamara van den Steent.m.van.den.steen@lacdr.leidenuniv.nl | 071 5272727
-
Jeltje van der SteenASSC
j.van.der.steen@assc.leidenuniv.nl | 071 5273179
-
Jasper van der SteenFaculty of Humanities
j.a.van.der.steen@hum.leidenuniv.nl | 071 5271492
-
Tommy van SteenFaculteit Governance and Global Affairs
t.van.steen@fgga.leidenuniv.nl | 070 8009500
-
Bart van der SteenLeiden University Libraries
b.s.van.der.steen@library.leidenuniv.nl | 071 5272727
-
Leiden researchers pioneer ‘green’ framework for sustainable drug development
Medical drugs are expensive to make and can have an adverse effect on the environment. Researchers Stefano Cucurachi and Justin Lian have developed a framework to help the healthcare system assess the economic and environmental sustainability of medical compounds.
-
Better understanding of cancer drugs – Leiden spin-off Omivera receives seed investment
How do you know if a drug will actually work? The Leiden-based spin-off Omivera is developing a new technology that could provide clearer answers. The young company received a seed investment from the investment fund UNIIQ to support its development.
-
Psychologist writes sober book about psychedelic drugs
Psychedelic drugs like magic mushrooms and LSD are embraced by some and seen as lethal by others. Cognitive psychologist Michiel van Elk delved into the world of psychedelic drugs and wrote a surprisingly sober book about them. ‘Without first-hand experience my story wouldn’t be complete.’
-
New platform to accelerate cardiac drug development
Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to develop a new platform that enables the automated production of 3D cardiac microtissues. This platform will allow large numbers of drugs to be tested quickly
-
How Leiden University is taking action against cancer
One in two people will be diagnosed with cancer. World Cancer Day on 4 February raises awareness of the impact of this devastating disease. Leiden University is conducting various studies aimed at preventing and controlling cancer. Below are just a few examples.
-
Student alcohol and drug abuse: what can staff do?
It’s vital that universities are able to recognise the signs of alcohol and drug misuse in students. Staff also have an important role to play in talking about substance use. ‘That one conversation can make a difference’, says Jitske Hoogervorst, an adviser at Brijder addiction treatment services.
-
Alexander Krosa.kros@chem.leidenuniv.nl | 071 5274234
-
Gerard van Westengerard@lacdr.leidenuniv.nl | 071 5273511
-
Laura Heitmanl.h.heitman@lacdr.leidenuniv.nl | 071 5274558
-
Skin researcher calls for multidisciplinary collaboration: ‘I want to pool expertise’
In dermatology, there should be a high level of multidisciplinary collaboration among institutes and specialists, Professor of Translational Dermatology, Robert Rissmann, will say in his inaugural lecture on 8 July. He is building an infrastructure that will put pre-clinical and clinical skin research…
-
Eline DekeysterFaculty of Social and Behavioural Sciences
e.a.g.dekeyster@fsw.leidenuniv.nl | 071 5272727
-
Meiling Gaom.gao@biology.leidenuniv.nl | 071 5276592
-
Oncode Accelerator funds preclinical development of cancer therapies
Through its Demonstrator Projects, the Dutch Oncode Accelerator consortium provides grants for preclinical cancer therapy development. The first call for these projects is open until September 2025.
-
Marije Niemeijerm.c.niemeijer@lacdr.leidenuniv.nl | 071 5276105
-
Bas ter Braaks.j.ter.braak@lacdr.leidenuniv.nl | 071 5272727
-
Madeline Kavanaghm.e.kavanagh@lic.leidenuniv.nl | 071 5272727
-
RARE-NL: LUMC joins consortium to find treatments for rare diseases
RARE-NL, a new collaboration between university hospitals, hopes to find treatments for rare diseases. Professor Teun van Gelder is representing the LUMC in the initiative.
-
Margo Donam.a.dona@biology.leidenuniv.nl | 071 5272727
-
Anita Liaoc.liao@lacdr.leidenuniv.nl | 071 5272727
-
Erik Danene.danen@lacdr.leidenuniv.nl | 071 5274486
-
ICT-contact persons
For each university unit, the ICT Shared Service Centre (ISSC) has an appointed ICT contact person responsible for applying for ICT facilities for research, teaching and operational management.
-
Roxanne Kieltykar.e.kieltyka@chem.leidenuniv.nl | 071 5274441
-
Serkan Aslans.aslan@lacdr.leidenuniv.nl | 071 5275919
-
Sebastian Pompluns.j.pomplun@lacdr.leidenuniv.nl | 071 5274651
-
Coen van Hasseltcoen.vanhasselt@lacdr.leidenuniv.nl | 071 5273266
-
Anthe Janssena.p.a.janssen@lic.leidenuniv.nl | 071 5272727
-
Vici grants for research into antibodies, galaxies and Indigenous communities
Three Leiden researchers have been awarded a Vici grant by the Dutch Research Council. The funding of up to 1.5 million euros supports ‘talented, adventurous and pioneering researchers’. A total of 39 projects at Dutch institutions will receive a grant.
-
Thomas Hankemeierhankemeier@lacdr.leidenuniv.nl | 071 5274226
-
Olivier Béquignono.j.m.bequignon@lacdr.leidenuniv.nl | 071 5272727
-
Doctors discover a simple method to predict the risk of brain tumour recurrence
The risk of a brain tumour recurring can be predicted more accurately by counting the number of immune cells in the tumour under a microscope. These are the findings from research conducted by LUMC, Erasmus MC and Heidelberg University.
-
Daisy Batenburgd.batenburg@lacdr.leidenuniv.nl | 071 5272727
-
Kim Elbertsek.elbertse@lacdr.leidenuniv.nl | 071 5272727
-
Elsa Neuberte.neubert@lacdr.leidenuniv.nl | 071 5272727
-
Andraniek Evadgian -
Myrtille Koerselmanm.e.koerselman@lacdr.leidenuniv.nl | 071 5276270
-
Kostas Tassisk.tassis@lacdr.leidenuniv.nl | 071 5276302
-
Leo Pricelsprice@lacdr.leidenuniv.nl | 071 5272727
-
Marc Boefm.a.boef@lacdr.leidenuniv.nl | 071 5272727
-
Nada Badrn.badr@lacdr.leidenuniv.nl | 071 5272727
-
Bola Khalilb.a.a.khalil@lacdr.leidenuniv.nl | 071 5272727
-
Matthijs Vlasveldm.p.vlasveld@lacdr.leidenuniv.nl | 071 5272727
-
Linde Schoenmakerl.schoenmaker@lacdr.leidenuniv.nl | 071 5274607
-
Daan Jiskootd.a.jiskoot@lacdr.leidenuniv.nl | 071 5272727